We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,150

Let’s talk inFuse

  • Dechert LLP
  • -
  • USA
  • -
  • March 26 2015

The InFuse litigation has certainly given us quite a lot to talk about and almost all of it positive. It has been a treasure trove for defendants

Proposition 65 claims and 4-MeI: proving that deference to the FDA is necessary.

  • Bryan Cave LLP
  • -
  • USA
  • -
  • March 26 2015

Plaintiffs have made food labeling class actions a rapidly-growing field in recent years, particularly in the Northern District of California. They

No Medical Device Act preemption for inadequate product warnings claims

  • Jenner & Block
  • -
  • USA
  • -
  • March 25 2015

In McClellan v. I-Flow Corp., 776 F.3d 1035 (9th Cir. 2015) (No. 11-35109), the Ninth Circuit reviewed the decision of a district court to exclude

One-a-day keeps the plaintiff’s lawyers away: FDA determinations on disease claims preempt class action allegations

  • Kelley Drye & Warren LLP
  • -
  • USA
  • -
  • March 20 2015

A California court recently dismissed, in part, a consumer class action against labeling and advertising claims for twenty different Bayer One-A-Day

An atypical view of causation and harm from South Carolina

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 20 2015

We have had some time now to ruminate over the South Carolina Supreme Court's opinion in State of South Carolina ex rel. Wilson v

Notes from the off-label underground

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 19 2015

Keeping track of litigation over off-label usepromotion frequently sends us off on tangents. We've wandered into abortion cases,securities law cases

Plaintiffs’ experts’ “cherry-picking” of scientific studies not permitted

  • Gordon & Rees LLP
  • -
  • USA
  • -
  • March 17 2015

On February 20, 2015, New Jersey Superior Court Judge Nelson C. Johnson issued a decision in the New Jersey Accutane Multicounty Litigation that, if

Court finds that class action plaintiffs’ false advertising claims are stripped Bayer based on federal preemption

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • March 17 2015

In the recent case of Gallagher v. Bayer AG, Case No. 14-cv-04601-WHO (N.D. Cal. March 10, 2015), the plaintiffs asserted that the defendants Bayer

Not so atypical sales rep behavior

  • Dechert LLP
  • -
  • USA
  • -
  • March 17 2015

We confess that among the many benefits of being a DDL blogger, one of our favorites is our ability to have a little fun. Let's face it, legal

Ask your doctor

  • Weil Gotshal & Manges LLP
  • -
  • USA
  • -
  • March 16 2015

Doctors are smart folks who want to do the right thing for their patients. By and large, they want more information, not less. By and large, they